Balyasny Asset Management »

Elevation Oncology shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 3.1M 5.13

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Pioneer Natural Resources Put Option (PXD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
JPMorgan Chase & Co. Call Option (JPM)
Hess Call Option (HES)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Asml Holding N V N Y Registry Shs Call Option (ASML)

View all positions for Balyasny Asset Management

Top funds holding Elevation Oncology

Farallon Capital Management
Point72 Asset Management
Tang Capital Management
Balyasny Asset Management
Aisling Capital Management
venBio Partners
Braidwell
Qiming U.S. Ventures Management
Darwin Global Management
BVF
Citadel Advisors
Vanguard Group
Artal Group
Hudson Bay Capital Management
Palo Alto Investors

View all funds holding Elevation Oncology